35 unknown. 35 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 35 | Unknown 35 |
| Phase 2 | 4 | Unknown 4 |
Follow Urologic Neoplasms: new trials by email Literature Review of Urologic Neoplasms trials Research Report on Urologic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC) BCG for Therapeutic Use - Non-Muscle Invasive Bladder Cancer | Phase 3 | Unknown | Chengdu CoenBiotech Co., Ltd | 412 | 2023-12-28 | 2024-02-05 |
| Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer Carboplatin-Gemcitabine Cisplatin-Gemcitabine - Urinary Bladder Cancer | Phase 3 | Unknown | Assiut University | 20 | 2022-11-01 | 2024-07-30 |
| Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery Meropenem 1000 mg, Amoxicillin+clavulanic acid 1200 mg or Cefuroksim 1500mg - Bladder Cancer | Phase 3 | Unknown | N.N. Petrov National Medical Research Center of Oncology | 98 | 2022-02-02 | 2022-05-31 |
| A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients APL-1202, Epirubicin Hydrochloride - Non-muscle Invasive Bladder Cancer | Phase 3 | Unknown | Jiangsu Yahong Meditech Co., Ltd aka Asieris | 800 | 2021-09-29 | 2022-02-22 |
| A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line KidneyPRO, standard follow-up - Renal Cell Carcinoma Metastatic | Phase 3 | Unknown | Weprom | 178 | 2021-06-07 | 2022-05-03 |
| Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer VB4-845 Injection - Non-Muscle Invasive Bladder Cancer | Phase 3 | Unknown | Qilu Pharmaceutical Co., Ltd. | 53 | 2021-03-23 | 2021-04-26 |
| Fast Track Protocol After Radical Cystectomy and Urinary Diversion: A Randomised Controlled Trial. Fast Track Protocol - Bladder Cancer | Phase 3 | Unknown | Mansoura University | 200 | 2021-01-15 | 2021-06-25 |
| Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer BCG instillation therapy, Sequential BCG and EMDA mitomycin C - Bladder Cancer | Phase 3 | Unknown | Turku University Hospital | 300 | 2018-10-26 | 2021-04-01 |
| Assessment of BladderLight SurvEILlance BladderLight® - Bladder Cancer | Phase 2 / Phase 3 | Unknown | Cambridge University Hospitals NHS Foundation Trust | 2100 | 2018-02-01 | 2018-02-09 |
| Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients APL-1202 in combination with Epirubicin, Placebo in combination with Epirubicin - Non-muscle Invasive Bladder Cancer | Phase 3 | Unknown | Jiangsu Yahong Meditech Co., Ltd aka Asieris | 359 | 2017-03-30 | 2022-02-22 |
| A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer Thulium Laser en Bloc Resection of bladder tumor, Electrical transurethral resection of bladder tumor - Bladder Cancer | Phase 3 | Unknown | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 172 | 2017-01-01 | 2016-11-01 |
| Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy pemetrexed, Folic Acid, Vitamin B12 Injection - Bladder Cancer, Ureter Cancer | Phase 3 | Unknown | Asan Medical Center | 74 | 2017-01-01 | 2017-06-21 |
| Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium Minocycline, Placebo - Prostate Cancer, Carcinoma of the Rectum | Phase 3 | Unknown | RenJi Hospital | 750 | 2016-11-01 | 2020-01-28 |
| Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma Treatment duration of cisplatin based chemotherapy - Bladder Cancer, Ureter Cancer | Phase 3 | Unknown | Asan Medical Center | 330 | 2016-09-01 | 2017-09-28 |
| Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer Gemcitabine, Cisplatin - Bladder Cancer | Phase 3 | Unknown | Southwest Hospital, China | 200 | 2014-03-01 | 2014-02-28 |
| Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer Bacillus of Calmette-Guerin (BCG), Mitomycin (MM) - Bladder Cancer | Phase 3 | Unknown | University of Sydney | 501 | 2013-07-01 | 2023-06-18 |
| Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome decitabine - Acute Myelocytic Leukemia, Myelodysplastic Syndromes | Phase 2 / Phase 3 | Unknown | The First Affiliated Hospital of Soochow University | 15 | 2013-01-01 | 2013-03-12 |
| Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9) white light TUR-BT, blue light TUR-BT, optimized MMC - Bladder Cancer | Phase 3 | Unknown | Turku University Hospital | 400 | 2012-12-01 | 2023-04-13 |
| Efficacy of Diclofenac BCG Irrigations Abitren, Placebo - Bladder Cancer | Phase 3 | Unknown | Carmel Medical Center | 100 | 2012-05-01 | 2012-05-22 |
| Clinical Trial Using Bipolar Technology for Transurethral Resection of Bladder Tumor Monopolar diathermy, Bipolar diathermy - Urinary Bladder Tumor | Phase 3 | Unknown | Chinese University of Hong Kong | 150 | 2012-05-01 | 2015-02-04 |
Showing 20 of 35. Sign in to see all of them.
Urinary Bladder Neoplasms (23) · Carcinoma, Renal Cell (5) · Non-Muscle Invasive Bladder Neoplasms (5) · Recurrence (4) · Carcinoma, Transitional Cell (3) · Kidney Neoplasms (3) · Wilms Tumor (3) · Prostatic Neoplasms (2) · Rectal Neoplasms (2) · Ureteral Neoplasms (2) · Carcinoma, Ovarian Epithelial (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Emergence Delirium (1) · Endometrial Neoplasms (1)
Female Urogenital Diseases (35) · Female Urogenital Diseases and Pregnancy Complications (35) · Male Urogenital Diseases (35) · Neoplasms by Site (35) · Urogenital Diseases (35) · Urogenital Neoplasms (35) · Urologic Diseases (35) · Neoplasms (34) · Urinary Bladder Diseases (27) · Neoplasms by Histologic Type (17) · Carcinoma (14) · Neoplasms, Glandular and Epithelial (14) · Kidney Diseases (8) · Pathological Conditions, Signs and Symptoms (6)
Epirubicin (3) · Gemcitabine (3) · BCG Connaught (2) · BCG Vaccine (2) · Chemoprevention (2) · Chemotherapy, Adjuvant (2) · Cisplatin (2) · Dactinomycin (2) · Gene Expression Profiling (2) · Mitomycin (2) · Selenium (2) · Vincristine (2) · Vitamin E (2) · Amoxicillin-Potassium Clavulanate Combination (1) · Biopsy (1)
Asan Medical Center (2) · Jiangsu Yahong Meditech Co., Ltd aka Asieris (2) · Turku University Hospital (2) · University of Leicester (2) · Anthra Pharmaceuticals (1) · Assiut University (1) · Association of Urologic Oncology (AUO) (1) · Bozyaka Training and Research Hospital (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Cancer Research Campaign Clinical Trials Centre (1) · Carmel Medical Center (1) · Charite University, Berlin, Germany (1) · Chengdu CoenBiotech Co., Ltd (1) · Chinese University of Hong Kong (1) · European Organisation for Research and Treatment of Cancer - EORTC (1)
United Kingdom (8) · China (7) · France (3) · Germany (3) · Italy (3) · Netherlands (3) · Belgium (2) · Canada (2) · Egypt (2) · Finland (2) · Japan (2) · South Korea (2) · Australia (1) · Croatia (1) · Czechia (1)
Jan DeKraker, MD (2) · Ahmed Lashin, Dr. (1) · Ahmed Mosbah, Prof. (1) · Ali R Ayder, MD (1) · Axel Bex (1) · Camillo F. Pollera, MD (1) · Dickon Hayne (1) · Dingwei Ye, MD,PhD (1) · Dingwei Ye, PI (1) · Eddie SY Chan, MD (1) · Eero Kaasinen, Md, PhD (1) · Fatih Duz, MD (1) · Francois Pein, MD (1)
PMID 11001674, PMID 10463285, PMID 11844814, PMID 15175957, PMID 15542800, PMID 1607913, PMID 16330205, PMID 16389183, PMID 16849761, PMID 17084075, PMID 18024869, PMID 18685414, PMID 18811224, PMID 19231157, PMID 19300220, PMID 19687335, PMID 20332316, PMID 20582946, PMID 21703848, PMID 23228299, PMID 23835707, PMID 24055428, PMID 24338498, PMID 25720673, PMID 26001531, PMID 26845426, PMID 30274699, PMID 30543350, PMID 32466961, PMID 35094962, PMID 37146227, PMID 39080350, PMID 39355793